Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs

Abstract:
Iranian researchers produced anti-breast-cancer drug by using Artemisia annua plant.

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs

Tehran, Iran | Posted on August 29th, 2015

The drug has been produced and analyzed at laboratorial scale, and it has successful effects in reducing the size of breast cancer tumors in animal samples.

Artemisinin is the active pharmaceutical ingredient (API) of Artemisia annua plant. Artemisinin has more toxicity on cancer cells in the presence of iron and transferrin. In this research, targeted magnetic nanoliposomes containing artemisinin and holo-transferrin were produced and in-vitro studies were carried out on their anticancer effect on breast cancer cells (MCF-7). In-vivo studies were also carried out on mice suffering from breast cancer.

Based on the results, the functionalization of nanoliposomes with magnetic iron nanoparticles facilitates drug delivery to the tumors. In addition, a significant increase is observed in the efficiency of the entrapped drug in the elimination of breast tumor in the sample animals.

According to the researchers, magnetic nanoliposomes containing artemisinin and transferrin were produced in this research through extrusion method, and some of their physical and chemical properties were studied. Next, in-vitro studies were carried out on the toxicity of the produced nanoliposomes through MTT method on MCF-7 cancer cells.

Results showed that the amount of artemisinin and transferrin in the tumor increased 10 and 5.5 times respectively in comparison with the complex created with the free form of the drugs two hours after the injection of magnetic nanoliposomes containing medication in the presence of magnetic field. In addition, the tumor volume in the sample mice significantly reduced in 15 days due to the presence of the magnetic field.

Results of the research have been published in PHARMACOGNOSY MAGAZINE, vol. 11, issue 42, 2015, pp. 117-122.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Cancer

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project